Eric Smith serves as the Director of Translational Research for Immune Effector Cell Therapies at Dana-Farber Cancer Institute. An MD from the Icahn School of Medicine, he focuses on translating preclinical discoveries, especially cell-based therapies for myeloma, from the lab into clinical practice.
He is deeply engaged with the patient advocacy community, drawing inspiration from their stories to advance cell and gene therapy. Eric values scientific collaboration and mentorship, frequently crediting his colleagues and team for their collective success in research and patient care.
Dr. Smiths preclinical work has resulted in nine awarded or pending patents, with several products from his lab being translated into the clinic.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.